D.E. Shaw & Co’s Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50 ACII.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-19,172
Closed -$1K 5545
2022
Q3
$1K Hold
19,172
﹤0.01% 5134
2022
Q2
$3K Hold
19,172
﹤0.01% 5269
2022
Q1
$6K Hold
19,172
﹤0.01% 5452
2021
Q4
$16K Hold
19,172
﹤0.01% 5309
2021
Q3
$16K Buy
+19,172
New +$20.3K ﹤0.01% 4908

D.E. Shaw & Co's ACII.WS Position: Q4 2022 in Review

D.E. Shaw & Co sold out of Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50 (ACII.WS) in Q4 2022, closing a stake of 19,172 shares — an estimated $1K sold.

D.E. Shaw & Co first reported a position in ACII.WS in Q3 2021 and held it in 5 quarters. The position peaked at $16K in Q4 2021. 0 funds tracked by Wall St. Rank hold ACII.WS as of Q4 2022.

  • D.E. Shaw & Co reported no remaining Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50 position as of Q4 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 19,172 Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50 shares in Q4 2022, an estimated $1K.
  • D.E. Shaw & Co first reported a position in Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50 in Q3 2021 and held it in 5 quarters.
  • D.E. Shaw & Co's Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50 position peaked at $16K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50 as of Q4 2022.

Based on D.E. Shaw & Co's 13F filing for Q4 2022, filed 14 Feb 2023.